ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

About ASN

Crystal A. Gadegbeku, MD, FASN, Councilor

ASN Biography

Crystal A. Gadegbeku, MD, FASN, is Professor of Medicine and Section Chief of Nephrology, Hypertension and Kidney Transplantation at the Lewis Katz School of Medicine at Temple University. She is also Vice Chair of Community Outreach for the Department of Medicine and a Medical Director of the FMC Episcopal Hospital Dialysis Unit. A graduate of the University of Virginia School of Medicine, Dr. Gadegbeku also completed her internal medicine residency and nephrology fellowship at the University of Virginia Hospital, and she has held board certifications in both disciplines.

Her research career has focused on clinical and translational investigation in vascular biology and chronic kidney disease, specifically mechanisms of hypertension and accelerated cardiovascular disease in patients with chronic kidney disease. She has held leadership roles for recruitment and retention for NIH-sponsored multi-site studies with diverse populations including the AASK trial, CRIC, and currently NEPTUNE, and served as Core Director for the kidney disease cohort of the Michigan Kidney Translational Center of Excellence (P30). Recently, she has been invited to participate in the NIDDK Strategic Plan as part of an NIH-wide initiative under the 21st Century Cures Act. Her clinical interests include management of resistant hypertension, hypertension in pregnancy, and progressive chronic kidney disease.

Dr. Gadegbeku’s involvement with ASN includes being a founding member of the Diversity and Inclusion Workgroup, now Committee, a member of the Public Policy Board and serving as Chair for the Policy and Advocacy Committee. Highlights from her ASN involvement include witnessing the growth of diversity initiatives in ASN, the launch of KidneyX and the American Advancing Kidney Health Executive Order.

Dr. Gadegbeku feels that ASN is well-positioned to be a voice for our dedicated community with a common mission to improve and sustain lives with kidney disease at a time where there are multiple challenges, from research to workforce to patient management, but also seeds of hope with strategies to innovate research, care, and policies.